[{"ATTACHMENTNAME":"f3c29ada-aa5c-4678-9453-a5ab61ed1914.pdf","NEWS_DT":"2020-10-19T17:22:48.743","QUARTER_ID":null,"CATEGORYNAME":"Company Update","HEADLINE":"Transcript of earning conference call held on October 14, 2020 for Financial results Q2FY2021","SCRIP_CD":540797,"AGENDA_ID":157,"NEWSSUB":"Announcement under Regulation 30 (LODR)-Earnings Call Transcript"},{"ATTACHMENTNAME":"1ef77f70-2dfd-481f-b597-fccac1f23c49.pdf","NEWS_DT":"2021-11-02T18:43:23.513","QUARTER_ID":null,"CATEGORYNAME":"Company Update","HEADLINE":"Transcript of Earning Conference Call held on October 28, 2021 for Q2 FY 2021-22 Unaudited Financial Results","SCRIP_CD":540797,"AGENDA_ID":157,"NEWSSUB":"Announcement under Regulation 30 (LODR)-Earnings Call Transcript"},{"ATTACHMENTNAME":"5d020eba-6cf8-4928-b536-1e4176a954cb.pdf","NEWS_DT":"2021-08-16T15:28:20.857","QUARTER_ID":null,"CATEGORYNAME":"Company Update","HEADLINE":"Transcript of Conference (Earning) Call held on 12th August 2021","SCRIP_CD":540797,"AGENDA_ID":157,"NEWSSUB":"Announcement under Regulation 30 (LODR)-Earnings Call Transcript"},{"ATTACHMENTNAME":"41431736-eb2a-42b2-afc0-b42d865f29f4.pdf","NEWS_DT":"2021-05-22T17:02:13.12","QUARTER_ID":null,"CATEGORYNAME":"Company Update","HEADLINE":"With reference to earlier intimation vide our letter no. Shalby/SE/2021-22/26 dated May 17, 2021 and pursuant to Regulation 30 of SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith transcript of Conference Call held on May 18, 2021 wherein recent Acquisition of Implant Assets from Consensus Orthopedics were discussed. The said transcript is also available in the Investors Section of our website.","SCRIP_CD":540797,"AGENDA_ID":1,"NEWSSUB":"Transcript Of Conference Call Held On May 18, 2021 To Discuss Recent Acquisition Of Implant Assets From Consensus Orthopedics"},{"ATTACHMENTNAME":"0d5a4a78-bde1-4857-9c5b-0f3b85be053e.pdf","NEWS_DT":"2021-05-12T10:37:38.14","QUARTER_ID":null,"CATEGORYNAME":"Company Update","HEADLINE":"Transcript of earning conference call held on May 7, 2021 for 44 and FY 2020-21 Audited Financial Results","SCRIP_CD":540797,"AGENDA_ID":157,"NEWSSUB":"Announcement under Regulation 30 (LODR)-Earnings Call Transcript"},{"ATTACHMENTNAME":"072b1d45-9d9d-415f-9971-e4519f658783.pdf","NEWS_DT":"2021-01-18T10:01:23.313","QUARTER_ID":null,"CATEGORYNAME":"Company Update","HEADLINE":"Transcript of earning conference call held on January 11, 2021 for Q3FY2021 financial results","SCRIP_CD":540797,"AGENDA_ID":157,"NEWSSUB":"Announcement under Regulation 30 (LODR)-Earnings Call Transcript"},{"ATTACHMENTNAME":"eab9be71-24c7-4173-b9aa-8f9d561eecaa.pdf","NEWS_DT":"2022-06-03T16:24:08.07","QUARTER_ID":null,"CATEGORYNAME":"Company Update","HEADLINE":"Transcript of Earning Call for Q4 and FY 2022 held on May 31, 2022","SCRIP_CD":540797,"AGENDA_ID":157,"NEWSSUB":"Announcement under Regulation 30 (LODR)-Earnings Call Transcript"},{"ATTACHMENTNAME":"a7286a91-a7a7-4a89-b664-727565e113e6.pdf","NEWS_DT":"2022-02-08T11:18:10.96","QUARTER_ID":null,"CATEGORYNAME":"Company Update","HEADLINE":"Transcript of Earning Call held on February 4, 2022 for discussion on unaudited financial results for quarter and nine months ended December 31, 2021","SCRIP_CD":540797,"AGENDA_ID":157,"NEWSSUB":"Announcement under Regulation 30 (LODR)-Earnings Call Transcript"}]